DramPharma is a company that manufactures and sells medicine to treat Huntington's disease, a rare genetic disorder. The company controls 80 percent of the world's industry in its segment. The company aims to seek steady growth in the industry. In terms of adaptive strategies, DramPharma would most likely be categorized as a(n) _____.